tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage
The FlyAstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage
2d ago
AZN
AstraZeneca reports Q1 core EPS $2.06, consensus $1.22
PremiumThe Fly
AstraZeneca reports Q1 core EPS $2.06, consensus $1.22
2d ago
AZN
AstraZeneca Sees Strong Growth in Q1 2024
PremiumCompany Announcements
AstraZeneca Sees Strong Growth in Q1 2024
2d ago
AstraZeneca put volume heavy and directionally bearish
PremiumThe Fly
AstraZeneca put volume heavy and directionally bearish
4d ago
AZN
AstraZeneca reports Voydeya approved in EU as PNH add-on treatment
PremiumThe Fly
AstraZeneca reports Voydeya approved in EU as PNH add-on treatment
4d ago
AZN
Unusually active option classes on open April 18th
PremiumThe FlyUnusually active option classes on open April 18th
9d ago
AZN
NOK
AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
PremiumThe Fly
AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
11d ago
AZN
AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC
PremiumThe Fly
AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC
11d ago
AZN
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
PremiumThe Fly
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
11d ago
AZN
UK Stocks: AstraZeneca (AZN) Assures Dividend Growth Before CEO Pay Vote
PremiumGlobal Markets
UK Stocks: AstraZeneca (AZN) Assures Dividend Growth Before CEO Pay Vote
16d ago
AstraZeneca announces FDA approval for Fasenra
PremiumThe Fly
AstraZeneca announces FDA approval for Fasenra
16d ago
AZN
AstraZeneca increases 2024 dividend by 7% to $3.10 per share
PremiumThe Fly
AstraZeneca increases 2024 dividend by 7% to $3.10 per share
16d ago
AZN
Roche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx
PremiumThe FlyRoche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx
17d ago
AZN
Nuvectis says NXP900 demonstrates robust activity in NSCLC
PremiumThe Fly
Nuvectis says NXP900 demonstrates robust activity in NSCLC
19d ago
AZN
NVCT
ENHERTU approved for treatment of unresectable or metastatic HER2 positive
PremiumThe Fly
ENHERTU approved for treatment of unresectable or metastatic HER2 positive
20d ago
AZN
AstraZeneca releases ADRIATIC Phase III trial results on IMFINZI
PremiumThe Fly
AstraZeneca releases ADRIATIC Phase III trial results on IMFINZI
22d ago
AZN
AstraZeneca: Imfinzi significantly improved OS and PFS in LS-SCLS in trial
PremiumThe Fly
AstraZeneca: Imfinzi significantly improved OS and PFS in LS-SCLS in trial
22d ago
AZN
AstraZeneca call volume above normal and directionally bullish
PremiumThe Fly
AstraZeneca call volume above normal and directionally bullish
23d ago
AZN
AstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan
PremiumThe Fly
AstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan
23d ago
AZN
AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S.
PremiumThe FlyAstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S.
25d ago
AZN
AstraZeneca announces FDA approval of Voydeya
PremiumThe Fly
AstraZeneca announces FDA approval of Voydeya
26d ago
AZN
AstraZeneca shareholders urged to oppose EUR 18.7M pay plan for CEO, FT says
PremiumThe Fly
AstraZeneca shareholders urged to oppose EUR 18.7M pay plan for CEO, FT says
26d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >